Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
seqWell’s plexWell Technology Selected by California Conservation Genomics Project for Conservation Genomics Research
seqWell, a global provider of next-generation sequencing (NGS) library technologies based on its proprietary plexWell™ […]
Adaptiiv Collaborates With HP and Varian To Enhance Personalization in Radiation Oncology With 3D Printed Medical Devices
Adaptiiv Medical Technologies Inc. (Adaptiiv) is collaborating with HP Inc. (HP) and Varian, a Siemens […]
Mologic and Alamar Biosciences Collaborate to Develop a next Generation COVID-19 Antigen Test
Alamar Biosciences (Alamar), a platform company focused on transforming the field of proteomics to enable […]
Overjet Partners with Dental Care Alliance, Providing AI to Improve Patient Outcomes
Overjet, a leader in dental artificial intelligence solutions for providers and payers, today announced a […]
Gilead and Dragonfly Announce Strategic Research Collaboration to Develop Natural Killer Cell Engagers in Oncology and Inflammation
Gilead Sciences, Inc. (Nasdaq: GILD) and Dragonfly Therapeutics today announced a collaboration designed to advance […]
LifeOmic Deploys AI Solution With xCures to Improve Cancer Research and Treatment
LifeOmic, a software company that leverages the cloud, machine learning and mobile devices to power […]
Abbott, CamDiab and Ypsomed Unveil New Automated Insulin Delivery Partnership for People with Diabetes
Abbott (NYSE: ABT), CamDiab and Ypsomed today announced that they are partnering to develop and commercialize […]
Quell Therapeutics and Cellistic™ Enter a Strategic Collaboration to Develop an iPSC-derived Allogeneic T-regulatory (Treg) Cell Therapy Platform
Quell Therapeutics Ltd (“Quell”), a leader in developing engineered T-regulatory (Treg) cell therapies for serious […]
Codexis and seqWell Announce Strategic Investment and Partnership Initiation
Codexis, Inc. (Nasdaq: CDXS) and seqWell, Inc. today announced the initiation of a strategic partnership […]
Syndrome Post-COVID: First Results of the Collaboration Between Fondamental & GeNeuro
GeNeuro (Euronext Paris: CH0308403085 – GNRO), a biopharmaceutical company developing new treatments for neurodegenerative and autoimmune […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more